DNA Script develops enzymatic DNA synthesis technology, offering the SYNTAX platform and associated kits that enable laboratories to produce high-quality oligonucleotides in-house and on-demand. The company serves biotech companies, pharmaceutical firms, contract research organizations, core facilities, and governmental agencies seeking to streamline synthetic biology workflows.
Subscribe to see DNA Script’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DNA Script is a biotech company headquartered in France. Xcout tracks 12 named people at DNA Script, including Marc Montserrat (CEO). Xcout recorded 1 job posting from DNA Script in the last 90 days.
6 more named people on record for DNA Script, with roles, board committees and tenure — see the full roster →
Xcout recorded 1 job posting from DNA Script in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see DNA Script's hiring signals →
A few of DNA Script's closest competitors — see the full list of competitors and alternatives →
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Twist Bioscience Corp is headquartered in South San Francisco, California, and operates in the synthetic biology sector. The company manufactures and sells customized DNA synthesis products utilizing a silicon-based platform for various scientific applications.
Synhelix is a French biotechnology company founded in 2019 to develop affordable DNA synthesis technology and address the supply bottleneck of DNA constructs for biotherapeutics development. The company was acquired by Univercells to be incorporated into its affiliate Quantoom, expanding its operations into synthetic biology.
Watchmaker Genomics, Inc. is a U.S. biotechnology company developing enzyme-based tools and workflows for genomics, including next-generation sequencing library preparation and related DNA/RNA analysis applications. It serves research, clinical, and biopharmaceutical users that need high-performance molecular biology and sequencing technologies.
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
Integrated DNA Technologies manufactures and supplies custom nucleic acid products, including DNA and RNA oligonucleotides, qPCR assays, CRISPR genome editing tools, gene fragments, and next-generation sequencing reagents. The company serves researchers and life science professionals in academic, clinical, and industrial sectors.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.